{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:41:17Z","timestamp":1788910877457,"version":"build-2803163510"},"reference-count":161,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008571","name":"School of Medicine, Southern Illinois University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00788","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T07:47:03Z","timestamp":1574236023000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":81,"title":["Metabolic Syndrome and Skin Diseases"],"prefix":"10.3389","volume":"10","author":[{"given":"Yu","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Bartke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,20]]},"reference":[{"key":"B1","first-page":"281","article-title":"[Syndrome X]","volume":"80","author":"Favaro","year":"1989","journal-title":"Recenti Prog Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/1753944717711379","article-title":"Metabolic syndrome: pathophysiology, management, and modulation by natural compounds","volume":"11","author":"Rochlani","year":"2017","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ecl.2013.09.009","article-title":"Metabolic syndrome","volume":"43","author":"Samson","year":"2014","journal-title":"Endocrinol Metab Clin North Am."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clindermatol.2017.09.001","article-title":"Skin and the metabolic syndrome","volume":"36","author":"Karadag","year":"2018","journal-title":"Clin Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/jdi.12663","article-title":"Prevalence of metabolic syndrome in Chinese psoriasis patients: a hospital-based cross-sectional study","volume":"9","author":"Gui","year":"2018","journal-title":"J Diabetes Investig"},{"key":"B6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B7","first-page":"663","article-title":"Relationship between psoriasis and metabolic syndrome: a systematic review","volume":"151","author":"Singh","year":"2016","journal-title":"G Ital Dermatol Venereol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jaad.2017.04.1133","article-title":"Systematic review and meta-analysis of the association between psoriasis and metabolic syndrome","volume":"77","author":"Rodriguez-Zuniga","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0181039","DOI":"10.1371\/journal.pone.0181039","article-title":"An update on psoriasis and metabolic syndrome: a meta-analysis of observational studies","volume":"12","author":"Singh","year":"2017","journal-title":"PLoS ONE"},{"key":"B10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/jdv.15159","article-title":"Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study","volume":"33","author":"Fernandez-Armenteros","year":"2019","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1001\/jamadermatol.2015.4499","article-title":"Insulin resistance and metabolic syndrome in young men with acne","volume":"152","author":"Nagpal","year":"2016","journal-title":"JAMA Dermatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.5114\/pdia.2015.53047","article-title":"Insulin resistance in severe acne vulgaris","volume":"32","author":"Emiroglu","year":"2015","journal-title":"Postepy Dermatol Alergol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jaad.2019.04.009","article-title":"Acne and obesity: a nationwide study of 600,404 adolescents","volume":"81","author":"Snast","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1054\/mehy.1997.0624","article-title":"The hypogonadal-obesity cycle: role of aromatase in modulating the testosterone-estradiol shunt\u2013a major factor in the genesis of morbid obesity","volume":"52","author":"Cohen","year":"1999","journal-title":"Med Hypotheses"},{"key":"B15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.clindermatol.2016.10.004","article-title":"Sex hormones and acne","volume":"35","author":"Ju","year":"2017","journal-title":"Clin Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.juro.2015.04.079","article-title":"Age and obesity promote methylation and suppression of 5alpha-reductase 2: implications for personalized therapy of benign prostatic hyperplasia","volume":"194","author":"Bechis","year":"2015","journal-title":"J Urol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1001\/jama.2017.16691","article-title":"Hidradenitis suppurativa: advances in diagnosis and treatment","volume":"318","author":"Saunte","year":"2017","journal-title":"JAMA"},{"key":"B18","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/bjd.13777","article-title":"Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients","volume":"173","author":"Shalom","year":"2015","journal-title":"Br J Dermatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1001\/jamadermatol.2014.1165","article-title":"Association of metabolic syndrome and hidradenitis suppurativa","volume":"150","author":"Miller","year":"2014","journal-title":"JAMA Dermatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jaad.2013.11.014","article-title":"The prevalence of metabolic syndrome in patients with hidradenitis suppurativa","volume":"70","author":"Gold","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12020-017-1280-y","article-title":"Androgenetic alopecia: a review","volume":"57","author":"Lolli","year":"2017","journal-title":"Endocrine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4103\/0378-6323.174421","article-title":"Metabolic syndrome in androgenic alopecia","volume":"82","author":"Gopinath","year":"2016","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.aju.2016.01.003","article-title":"Benign prostatic hyperplasia, metabolic syndrome and androgenic alopecia: is there a possible relationship?","volume":"14","author":"Agamia","year":"2016","journal-title":"Arab J Urol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3109\/08037051.2015.1111021","article-title":"Androgenetic alopecia as an indicator of metabolic syndrome and cardiovascular risk","volume":"25","author":"Ertas","year":"2016","journal-title":"Blood Press"},{"key":"B25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1365-2133.2010.09816.x","article-title":"Association of androgenetic alopecia with metabolic syndrome in men: a community-based survey","volume":"163","author":"Su","year":"2010","journal-title":"Br J Dermatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"196","DOI":"10.4103\/ijem.IJEM_650_17","article-title":"Association of androgenetic alopecia with metabolic syndrome: a case-control study on 100 patients in a tertiary care hospital in South India","volume":"22","author":"Dharam Kumar","year":"2018","journal-title":"Indian J Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","first-page":"980310","DOI":"10.1155\/2015\/980310","article-title":"Is there really relationship between androgenetic alopecia and metabolic syndrome?","volume":"2015","author":"Ozbas Gok","year":"2015","journal-title":"Dermatol Res Pract."},{"key":"B28","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4103\/2229-5178.137776","article-title":"Androgenetic alopecia, metabolic syndrome, and insulin resistance: Is there any association? A case-control study","volume":"5","author":"Bakry","year":"2014","journal-title":"Indian Dermatol Online J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/ijd.13303","article-title":"Association of metabolic syndrome with female pattern hair loss in women: a case-control study","volume":"55","author":"El Sayed","year":"2016","journal-title":"Int J Dermatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.clindermatol.2017.09.008","article-title":"Acanthosis nigricans and the metabolic syndrome","volume":"36","author":"Karadag","year":"2018","journal-title":"Clin Dermatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1089\/met.2013.0145","article-title":"Relation of Acanthosis nigricans to metabolic syndrome in overweight and obese women","volume":"12","author":"Ayaz","year":"2014","journal-title":"Metab Syndr Relat Disord."},{"key":"B32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.endien.2016.09.002","article-title":"Association of metabolic syndrome with low birth weight, intake of high-calorie diets and acanthosis nigricans in children and adolescents with overweight and obesity","volume":"64","author":"Velazquez-Bautista","year":"2017","journal-title":"Endocrinol Diabetes Nutr"},{"key":"B33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1590\/1984-0462\/;2018;36;3;00017","article-title":"Association between acanthosis nigricans and other cardiometabolic risk factors in children and adolescents with overweight and obesity","volume":"36","author":"Palhares","year":"2018","journal-title":"Rev Paul Pediatr"},{"key":"B34","doi-asserted-by":"publisher","first-page":"591","DOI":"10.4103\/ijd.IJD_545_17","article-title":"Facial acanthosis nigricans: a morphological marker of metabolic syndrome","volume":"62","author":"Panda","year":"2017","journal-title":"Indian J Dermatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000370220","article-title":"Atopic dermatitis: global epidemiology and risk factors","volume":"66","author":"Nutten","year":"2015","journal-title":"Ann Nutr Metab."},{"key":"B36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2340\/00015555-2441","article-title":"Association between metabolic syndrome and atopic dermatitis in korean adults","volume":"97","author":"Lee","year":"2017","journal-title":"Acta Derm Venereol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/jdv.13813","article-title":"Prevalence and comorbidities in adults with psoriasis compared to atopic eczema","volume":"31","author":"Radtke","year":"2017","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000491593","article-title":"Association between atopic dermatitis and the metabolic syndrome: a systematic review","volume":"234","author":"Ali","year":"2018","journal-title":"Dermatology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.jaci.2011.01.063","article-title":"Association between obesity and atopic dermatitis in childhood: a case-control study","volume":"127","author":"Silverberg","year":"2011","journal-title":"J Allergy Clin Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jaad.2014.12.013","article-title":"Association of atopic dermatitis with being overweight and obese: a systematic review and metaanalysis","volume":"72","author":"Zhang","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.clindermatol.2017.09.004","article-title":"Pathophysiology of the metabolic syndrome","volume":"36","author":"McCracken","year":"2018","journal-title":"Clin Dermatol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"B43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.clindermatol.2017.09.013","article-title":"Gynecologic and andrologic dermatology and the metabolic syndrome","volume":"36","author":"Roth","year":"2018","journal-title":"Clin Dermatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2310\/JIM.0b013e3182746f95","article-title":"Insulin signaling and insulin resistance","volume":"61","author":"Beale","year":"2013","journal-title":"J Investig Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrg1879","article-title":"The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism","volume":"7","author":"Engelman","year":"2006","journal-title":"Nat Rev Genet."},{"key":"B46","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1042\/bst0310292","article-title":"Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors","volume":"31","author":"Birkenkamp","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"B47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.gene.2018.01.051","article-title":"Role of Forkhead Box O (FOXO) transcription factor in aging and diseases","volume":"648","author":"Tia","year":"2018","journal-title":"Gene"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.bbamcr.2011.06.002","article-title":"FoxO transcription factors; Regulation by AKT and 14-3-3 proteins","volume":"1813","author":"Tzivion","year":"2011","journal-title":"Biochim Biophys Acta."},{"key":"B49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrm1837","article-title":"Critical nodes in signalling pathways: insights into insulin action","volume":"7","author":"Taniguchi","year":"2006","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.4161\/cc.8.8.8147","article-title":"How ERK1\/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?","volume":"8","author":"Mebratu","year":"2009","journal-title":"Cell Cycle."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol Rev"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.mcna.2007.06.012","article-title":"Insulin resistance as the underlying cause for the metabolic syndrome","volume":"91","author":"Lann","year":"2007","journal-title":"Med Clin North Am."},{"key":"B53","doi-asserted-by":"publisher","first-page":"8152","DOI":"10.1002\/jcp.27603","article-title":"Insulin resistance: review of the underlying molecular mechanisms","volume":"234","author":"Yaribeygi","year":"2019","journal-title":"J Cell Physiol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"82S","DOI":"10.1111\/1523-1747.ep12462293","article-title":"Excess insulin binding to insulin-like growth factor receptors: proposed mechanism for acanthosis nigricans","volume":"98","author":"Cruz","year":"1992","journal-title":"J Invest Dermatol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/sj.ijo.0800412","article-title":"Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone","volume":"21","author":"Nam","year":"1997","journal-title":"Int J Obes Relat Metab Disord."},{"key":"B56","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrc3720","article-title":"IGF binding proteins in cancer: mechanistic and clinical insights","volume":"14","author":"Baxter","year":"2014","journal-title":"Nat Rev Cancer."},{"key":"B57","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.clindermatol.2004.01.001","article-title":"Obesity and dermatology","volume":"22","author":"Scheinfeld","year":"2004","journal-title":"Clin Dermatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"638526","DOI":"10.1155\/2015\/638526","article-title":"Targeting insulin-like growth factor binding protein-3 signaling in triple-negative breast cancer","volume":"2015","author":"Marzec","year":"2015","journal-title":"Biomed Res Int"},{"key":"B59","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/2229-5178.137765","article-title":"An approach to acanthosis nigricans","volume":"5","author":"Phiske","year":"2014","journal-title":"Indian Dermatol Online J"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s00125-010-1760-6","article-title":"Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling","volume":"53","author":"Sciacca","year":"2010","journal-title":"Diabetologia"},{"key":"B61","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/exd.12885","article-title":"Mechanistic target of rapamycin (mTOR) expression is increased in acne patients' skin","volume":"25","author":"Monfrecola","year":"2016","journal-title":"Exp Dermatol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/bjd.14409","article-title":"Skin expression of mammalian target of rapamycin and forkhead box transcription factor O1, and serum insulin-like growth factor-1 in patients with acne vulgaris and their relationship with diet","volume":"174","author":"Agamia","year":"2016","journal-title":"Br J Dermatol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1111\/jdv.13233","article-title":"Mammalian target of rapamycin, insulin resistance and hidradenitis suppurativa: a possible metabolic loop","volume":"30","author":"Monfrecola","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1111\/jdv.15271","article-title":"Insulin resistance, mTOR and hidradenitis suppurativa","volume":"33","author":"Marasca","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e964","DOI":"10.1038\/cddis.2013.506","article-title":"TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists","volume":"4","author":"Blagosklonny","year":"2013","journal-title":"Cell Death Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/MOL.0b013e328352dd03","article-title":"Connecting mTORC1 signaling to SREBP-1 activation","volume":"23","author":"Bakan","year":"2012","journal-title":"Curr Opin Lipidol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1007\/s13277-015-3047-5","article-title":"SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism","volume":"36","author":"Sun","year":"2015","journal-title":"Tumour Biol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.clindermatol.2017.09.006","article-title":"Acne vulgaris: the metabolic syndrome of the pilosebaceous follicle","volume":"36","author":"Melnik","year":"2018","journal-title":"Clin Dermatol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cellimm.2009.03.020","article-title":"The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease","volume":"258","author":"Ochaion","year":"2009","journal-title":"Cell Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.bbadis.2018.02.003","article-title":"PI3K\/AKT\/mTOR activation and autophagy inhibition plays a key role in increased cholesterol during IL-17A mediated inflammatory response in psoriasis","volume":"1864","author":"Varshney","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B71","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1007\/s11033-010-0544-x","article-title":"Comparison of gene expression profiles reveals aberrant expression of FOXO1, Aurora A\/B and EZH2 in lesional psoriatic skins","volume":"38","author":"Liu","year":"2011","journal-title":"Mol Biol Rep"},{"key":"B72","doi-asserted-by":"publisher","first-page":"7410","DOI":"10.1038\/sj.onc.1209086","article-title":"FOXO transcription factors at the interface between longevity and tumor suppression","volume":"24","author":"Greer","year":"2005","journal-title":"Oncogene"},{"key":"B73","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/bjd.12271","article-title":"Mammalian target of rapamycin and its downstream signalling components are activated in psoriatic skin","volume":"169","author":"Buerger","year":"2013","journal-title":"Br J Dermatol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.3389\/fimmu.2018.02786","article-title":"Epidermal mTORC1 signaling contributes to the pathogenesis of psoriasis and could serve as a therapeutic target","volume":"9","author":"Buerger","year":"2018","journal-title":"Front Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.2340\/00015555-2724","article-title":"Blocking mTOR signalling with rapamycin ameliorates imiquimod-induced psoriasis in mice","volume":"97","author":"Burger","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/exd.13461","article-title":"TNF stimulates IL-6, CXCL8 and VEGF secretion from human keratinocytes via activation of mTOR, inhibited by tetramethoxyluteolin","volume":"27","author":"Patel","year":"2018","journal-title":"Exp Dermatol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"e0180853","DOI":"10.1371\/journal.pone.0180853","article-title":"Inflammation dependent mTORC1 signaling interferes with the switch from keratinocyte proliferation to differentiation","volume":"12","author":"Buerger","year":"2017","journal-title":"PLoS ONE"},{"key":"B78","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00403-018-1879-8","article-title":"The role of PI3K\/AKT\/FOXO signaling in psoriasis","volume":"311","author":"Zhang","year":"2019","journal-title":"Arch Dermatol Res"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.7150\/ijbs.27173","article-title":"The PI3K\/AKT pathway in obesity and type 2 diabetes","volume":"14","author":"Huang","year":"2018","journal-title":"Int J Biol Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"T1","DOI":"10.1530\/JOE-13-0327","article-title":"Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms","volume":"220","author":"Guo","year":"2014","journal-title":"J Endocrinol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.yexmp.2007.05.002","article-title":"Expression and localization of the activated mitogen-activated protein kinase in lesional psoriatic skin","volume":"83","author":"Yu","year":"2007","journal-title":"Exp Mol Pathol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2133.2004.06304.x","article-title":"The mitogen-activated protein kinases p38 and ERK1\/2 are increased in lesional psoriatic skin","volume":"152","author":"Johansen","year":"2005","journal-title":"Br J Dermatol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.intimp.2018.11.031","article-title":"ERK inhibitor JSI287 alleviates imiquimod-induced mice skin lesions by ERK\/IL-17 signaling pathway","volume":"66","author":"Huang","year":"2019","journal-title":"Int Immunopharmacol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/toxsci\/kfx233","article-title":"Metabolic syndrome and associated diseases: from the bench to the clinic","volume":"162","author":"Mendrick","year":"2018","journal-title":"Toxicol Sci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11154-014-9301-0","article-title":"Adipocyte dysfunction, inflammation and metabolic syndrome","volume":"15","author":"Kloting","year":"2014","journal-title":"Rev Endocr Metab Disord."},{"key":"B86","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.stem.2017.03.015","article-title":"Repeal and replace: adipocyte regeneration in wound repair","volume":"20","author":"Horsley","year":"2017","journal-title":"Cell Stem Cell."},{"key":"B87","doi-asserted-by":"publisher","first-page":"a015271","DOI":"10.1101\/cshperspect.a015271","article-title":"Adipocytes in skin health and disease","volume":"4","author":"Rivera-Gonzalez","year":"2014","journal-title":"Cold Spring Harb Perspect Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1079\/BJN20041213","article-title":"Adipokines: inflammation and the pleiotropic role of white adipose tissue","volume":"92","author":"Trayhurn","year":"2004","journal-title":"Br J Nutr"},{"key":"B89","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fendo.2013.00071","article-title":"Adipokines mediate inflammation and insulin resistance","volume":"4","author":"Kwon","year":"2013","journal-title":"Front Endocrinol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1210\/en.2009-1098","article-title":"Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes","volume":"151","author":"Ernst","year":"2010","journal-title":"Endocrinology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.metabol.2011.10.008","article-title":"Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity","volume":"61","author":"Chakaroun","year":"2012","journal-title":"Metabolism"},{"key":"B92","doi-asserted-by":"publisher","first-page":"74","DOI":"10.5021\/ad.2016.28.1.74","article-title":"Association of adipokines, insulin resistance, hypertension and dyslipidemia in patients with psoriasis vulgaris","volume":"28","author":"Coban","year":"2016","journal-title":"Ann Dermatol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1002\/jcb.27936","article-title":"Chemerin\/ChemR23 axis triggers an inflammatory response in keratinocytes through ROS-sirt1-NF-kappaB signaling","volume":"120","author":"Wang","year":"2019","journal-title":"J Cell Biochem."},{"key":"B94","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1530\/eje.1.02175","article-title":"Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men","volume":"155","author":"Gannage-Yared","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/oby.2005.178","article-title":"Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity","volume":"13","author":"Franks","year":"2005","journal-title":"Obes Res."},{"key":"B96","first-page":"e25","article-title":"Elevated serum leptin levels in nonobese patients with psoriasis","volume":"12","author":"Aly","year":"2013","journal-title":"J Drugs Dermatol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1046\/j.1365-2133.2002.04703.x","article-title":"Serum leptin concentration is increased in patients with Behcet's syndrome and is correlated with disease activity","volume":"147","author":"Evereklioglu","year":"2002","journal-title":"Br J Dermatol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1111\/j.1468-3083.2011.04401.x","article-title":"Assessment of serum leptin, insulin resistance and metabolic syndrome in patients with skin tags","volume":"26","author":"Shaheen","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.jaad.2016.04.036","article-title":"Serum leptin and adiponectin levels in atopic dermatitis (AD) and their relation to disease severity","volume":"75","author":"Han","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e410","DOI":"10.1111\/ijd.12340","article-title":"Serum leptin, adiponectin, and resistin among adult patients with acanthosis nigricans: correlations with insulin resistance and risk factors for cardiovascular disease","volume":"53","author":"Atwa","year":"2014","journal-title":"Int J Dermatol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/bjd.13969","article-title":"The role of leptin in psoriasis comprises a proinflammatory response by the dermal fibroblast","volume":"174","author":"Ommen","year":"2016","journal-title":"Br J Dermatol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1365-2133.2008.08655.x","article-title":"Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation","volume":"159","author":"Johnston","year":"2008","journal-title":"Br J Dermatol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3889\/oamjms.2019.020","article-title":"Correlation between serum leptin level with type and number of lesion skin tag","volume":"7","author":"Putra","year":"2019","journal-title":"Open Access Maced J Med Sci"},{"key":"B104","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/01913123.2015.1006744","article-title":"Immunohistochemical evaluation of leptin role in skin tags","volume":"39","author":"Seleit","year":"2015","journal-title":"Ultrastruct Pathol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0006-291X(02)02841-3","article-title":"Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators","volume":"300","author":"Patel","year":"2003","journal-title":"Biochem Biophys Res Commun."},{"key":"B106","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1476-5381.2011.01369.x","article-title":"Resistin: functional roles and therapeutic considerations for cardiovascular disease","volume":"165","author":"Jamaluddin","year":"2012","journal-title":"Br J Pharmacol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1055\/a-0637-1975","article-title":"Correlation between resistin level and metabolic syndrome component: a review","volume":"50","author":"Mostafazadeh","year":"2018","journal-title":"Horm Metab Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1155\/2016\/3296437","article-title":"Resistin enhances inflammatory cytokine production in coronary artery tissues by activating the NF-\u03baB signaling %J BioMed Research International","volume":"2016","author":"Gao","year":"2016"},{"key":"B109","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2017.02.021","article-title":"PKC-epsilon and TLR4 synergistically regulate resistin-mediated inflammation in human macrophages","volume":"259","author":"Zuniga","year":"2017","journal-title":"Atherosclerosis"},{"key":"B110","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1159\/000481882","article-title":"Serum leptin, resistin, and adiponectin concentrations in psoriasis: a meta-analysis of observational studies","volume":"233","author":"Kyriakou","year":"2017","journal-title":"Dermatology"},{"key":"B111","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/biom8020017","article-title":"Association between resistin gene polymorphisms and atopic dermatitis","volume":"8","author":"Banihani","year":"2018","journal-title":"Biomolecules"},{"key":"B112","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/ced.13383","article-title":"Association of circulating resistin, leptin, adiponectin and visfatin levels with Behcet disease: a meta-analysis","volume":"43","author":"Lee","year":"2018","journal-title":"Clin Exp Dermatol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"423","DOI":"10.4155\/fmc-2018-0294","article-title":"Recent advances in developing PCSK9 inhibitors for lipid-lowering therapy","volume":"11","author":"Lavecchia","year":"2019","journal-title":"Future Med Chem."},{"key":"B114","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/jca.21695","article-title":"Real-world study: Escalating targeted lipid-lowering treatment with PCSK9-inhibitors and lipoprotein apheresis","volume":"34","author":"Spitthover","year":"2019","journal-title":"J Clin Apher."},{"key":"B115","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.jid.2018.07.046","article-title":"Potentiation of psoriasis-like inflammation by PCSK9","volume":"139","author":"Luan","year":"2019","journal-title":"J Invest Dermatol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"760691","DOI":"10.1155\/2013\/760691","article-title":"Evaluation of adipokines: apelin, visfatin, and resistin in children with atopic dermatitis","volume":"2013","author":"Machura","year":"2013","journal-title":"Mediators Inflamm."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s40618-015-0310-y","article-title":"Relation of resistin to proprotein convertase subtilisin-kexin type 9 levels in coronary artery disease patients with different nutritional status","volume":"38","author":"Li","year":"2015","journal-title":"J Endocrinol Invest."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/j.jacc.2011.11.064","article-title":"Discovery of a new role of human resistin in hepatocyte low-density lipoprotein receptor suppression mediated in part by proprotein convertase subtilisin\/kexin type 9","volume":"59","author":"Melone","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/cei.12768","article-title":"Immunometabolic biomarkers of inflammation in Behcet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens","volume":"184","author":"Cantarini","year":"2016","journal-title":"Clin Exp Immunol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s00417-015-3016-0","article-title":"Serum omentin, resistin and tumour necrosis factor-alpha levels in Behcet patients with and without ocular involvement","volume":"253","author":"Turkcu","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"9073","DOI":"10.1074\/jbc.M207198200","article-title":"Structure-function studies of the adipocyte-secreted hormone Acrp30\/adiponectin. Implications fpr metabolic regulation and bioactivity","volume":"278","author":"Pajvani","year":"2003","journal-title":"J Biol Chem."},{"key":"B122","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1590\/2359-3997000000316","article-title":"Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes: a literature review","volume":"61","author":"Frankenberg","year":"2017","journal-title":"Arch Endocrinol Metab"},{"key":"B123","doi-asserted-by":"publisher","first-page":"91","DOI":"10.7762\/cnr.2013.2.2.91","article-title":"Evaluation of adiposity-related biomarkers as metabolic syndrome indicators","volume":"2","author":"Bae","year":"2013","journal-title":"Clin Nutr Res"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.2337\/dc12-0223","article-title":"Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study","volume":"36","author":"Kim","year":"2013","journal-title":"Diabetes Care"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1172\/JCI29126","article-title":"Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome","volume":"116","author":"Kadowaki","year":"2006","journal-title":"J Clin Invest"},{"key":"B126","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jaad.2016.02.1220","article-title":"Dietary glycemic factors, insulin resistance, and adiponectin levels in acne vulgaris","volume":"75","author":"Cerman","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000452626","article-title":"Altered systemic adipokines in patients with chronic urticaria","volume":"171","author":"Trinh","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"7687","DOI":"10.1038\/ncomms8687","article-title":"Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from gammadelta-T cells","volume":"6","author":"Shibata","year":"2015","journal-title":"Nat Commun."},{"key":"B129","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.cyto.2014.12.014","article-title":"Cytokines in psoriasis","volume":"73","author":"Baliwag","year":"2015","journal-title":"Cytokine"},{"key":"B130","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00011-017-1065-z","article-title":"\u201cInflammatory skin march\u201d in atopic dermatitis and psoriasis","volume":"66","author":"Furue","year":"2017","journal-title":"Inflamm Res"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J Invest Dermatol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jaci.2014.08.008","article-title":"Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches","volume":"134","author":"Leung","year":"2014","journal-title":"J Allergy Clin Immunol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jid.2016.08.022","article-title":"Increasing comorbidities suggest that atopic dermatitis is a systemic disorder","volume":"137","author":"Brunner","year":"2017","journal-title":"J Invest Dermatol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/cr.2010.161","article-title":"A single NFkappaB system for both canonical and non-canonical signaling","volume":"21","author":"Shih","year":"2011","journal-title":"Cell Res."},{"key":"B135","doi-asserted-by":"publisher","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1021\/bi901948j","article-title":"Molecular mechanisms of system control of NF-kappaB signaling by IkappaBalpha","volume":"49","author":"Ferreiro","year":"2010","journal-title":"Biochemistry"},{"key":"B137","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"Shi","year":"2006","journal-title":"J Clin Invest"},{"key":"B138","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.tcb.2017.01.006","article-title":"Inflammation and the metabolic syndrome: the tissue-specific functions of NF-kappaB","volume":"27","author":"Catrysse","year":"2017","journal-title":"Trends Cell Biol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"35375","DOI":"10.1074\/jbc.M806480200","article-title":"S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2","volume":"283","author":"Zhang","year":"2008","journal-title":"J Biol Chem."},{"key":"B140","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40535-014-0003-1","article-title":"The immunological and genetic aspects in psoriasis","volume":"1","author":"Sun","year":"2014","journal-title":"Appl Inform."},{"key":"B141","doi-asserted-by":"publisher","first-page":"74236","DOI":"10.18632\/oncotarget.12371","article-title":"Overexpression and potential roles of NRIP1 in psoriasis","volume":"7","author":"Luan","year":"2016","journal-title":"Oncotarget"},{"key":"B142","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2017.04.023","article-title":"New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4\/NF-kappaB pathway","volume":"262","author":"Tang","year":"2017","journal-title":"Atherosclerosis"},{"key":"B143","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1038\/s41598-018-20425-x","article-title":"PCSK9 induces a pro-inflammatory response in macrophages","volume":"8","author":"Ricci","year":"2018","journal-title":"Sci Rep"},{"key":"B144","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1182\/blood-2007-11-121699","article-title":"Coactivator function of RIP140 for NFkappaB\/RelA-dependent cytokine gene expression","volume":"112","author":"Zschiedrich","year":"2008","journal-title":"Blood"},{"key":"B145","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/ni.2238","article-title":"NF-kappaB-mediated degradation of the coactivator RIP140 regulates inflammatory responses and contributes to endotoxin tolerance","volume":"13","author":"Ho","year":"2012","journal-title":"Nat Immunol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2011.06.008","article-title":"The MSC: an injury drugstore","volume":"9","author":"Caplan","year":"2011","journal-title":"Cell Stem Cell"},{"key":"B147","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/ijms18010208","article-title":"Mesenchymal stem cells from adipose tissue in clinical applications for dermatological indications and skin aging","volume":"18","author":"Gaur","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B148","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/cdd.2013.158","article-title":"Immunobiology of mesenchymal stem cells","volume":"21","author":"Ma","year":"2014","journal-title":"Cell Death Differ"},{"key":"B149","doi-asserted-by":"publisher","first-page":"2892840","DOI":"10.1155\/2016\/2892840","article-title":"Mesenchymal stem cells and metabolic syndrome: current understanding and potential clinical implications","volume":"2016","author":"Matsushita","year":"2016","journal-title":"Stem Cells Int"},{"key":"B150","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.trsl.2016.11.003","article-title":"Mesenchymal stromal cell-based therapies reduce obesity and metabolic syndromes induced by a high-fat diet","volume":"182","author":"Lee","year":"2017","journal-title":"Transl Res."},{"key":"B151","doi-asserted-by":"publisher","first-page":"466","DOI":"10.2174\/1574888X13666180515160008","article-title":"Adipose-derived mesenchymal stem cells in the treatment of obesity: a systematic review of longitudinal studies on preclinical evidence","volume":"13","author":"Saleh","year":"2018","journal-title":"Curr Stem Cell Res Ther"},{"key":"B152","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jdermsci.2015.12.007","article-title":"Immunosuppressive effect of adipose-derived stromal cells on imiquimod-induced psoriasis in mice","volume":"82","author":"Rokunohe","year":"2016","journal-title":"J Dermatol Sci."},{"key":"B153","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2147\/IMCRJ.S163612","article-title":"First-in-man intravenous implantation of stromal vascular fraction in psoriasis: a case study","volume":"11","author":"Comella","year":"2018","journal-title":"Int Med Case Rep J."},{"key":"B154","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.amjmed.2015.11.001","article-title":"Treatment of psoriasis with mesenchymal stem cells","volume":"129","author":"Chen","year":"2016","journal-title":"Am J Med."},{"key":"B155","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.3727\/096368916X691998","article-title":"Autologous adipose-derived mesenchymal stromal cells for the treatment of psoriasis vulgaris and psoriatic arthritis: a case report","volume":"25","author":"De Jesus","year":"2016","journal-title":"Cell Transplant."},{"key":"B156","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/jdv.13934","article-title":"Mesenchymal stromal cells: properties and role in management of cutaneous diseases","volume":"31","author":"Kim","year":"2017","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s12015-018-9809-x","article-title":"Dysfunction of mesenchymal stem cells isolated from metabolic syndrome and type 2 diabetic patients as result of oxidative stress and autophagy may limit their potential therapeutic use","volume":"14","author":"Kornicka","year":"2018","journal-title":"Stem Cell Rev."},{"key":"B158","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13287-015-0029-x","article-title":"Stromal-vascular fraction content and adipose stem cell behavior are altered in morbid obese and post bariatric surgery ex-obese women","volume":"6","author":"Silva","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellimm.2016.12.005","article-title":"Toll-like receptors as a key regulator of mesenchymal stem cell function: an up-to-date review","volume":"315","author":"Shirjang","year":"2017","journal-title":"Cell Immunol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3727\/096368913X667510","article-title":"Melatonin pretreatment improves the survival and function of transplanted mesenchymal stem cells after focal cerebral ischemia","volume":"23","author":"Tang","year":"2014","journal-title":"Cell Transplant"},{"key":"B161","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fcell.2017.00028","article-title":"TGF-beta1 pretreatment improves the function of mesenchymal stem cells in the wound bed","volume":"5","author":"Ghosh","year":"2017","journal-title":"Front Cell Dev Biol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00788\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T07:47:09Z","timestamp":1574236029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00788\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,20]]},"references-count":161,"alternative-id":["10.3389\/fendo.2019.00788"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00788","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,20]]},"article-number":"788"}}